Name: reprogramming primary amniotic fluid and membrane cells to pluripotency in xeno-free conditions
Uploaded: 2017-11-27T13:00:00
Description: Watch this Scientific Journal Video about Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions at JoVE.com

Dette arbejde blev støttet af Fonds Medizinische Forschung på universitetet i Zürich, Forschungskredit af universitetet i Zürich, The SCIEX NMSCh under stipendier 10.216 og 12.176, den schweiziske samfund kardiologi, The Swiss National Science Fundamentet under Grant [320030-122273] og [310030-143992], 7. rammeprogram, liv ventil, Europa-Kommissionen under tilskud [242008], Olga Mayenfisch Foundation, EMDO Foundation, starttilskud 2012 af Zürich Universitetshospital og interne finansiering af Mitchell Cancer Institute.

Protokollen følger institutionelle retningslinjer fra den etiske komité for human forskning. Skriftlig samtykke fra patienten blev opnået for anvendelse af fostervand til forskning.
Denne protokol følger institutionelle Animal Care og brug Udvalget af University of South Alabama politikker.
1. isolering og kultur af primære fostervand mesenkymale stamceller
<ol><li>
Plettering af fostervand væske celler
	<ol>
<li>Få mindst 2,5 mL fostervand...

<ol>
	<li>Takahashi, K., Yamanaka, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Induction+of+pluripotent+stem+cells+from+mouse+embryonic+and+adult+fibroblast+cultures+by+defined+factors.">Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.</a> Cell. 126 (4), 663-676 (2006).</li><li>Yu, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Induced+Pluripotent+Stem+Cell+Lines+Derived+from+Human+Somatic+Cells.">Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells.</a> Science. 318 (5858), 1917-1920 (2007).</li><li>Trounson, A., DeWitt, N. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pluripotent+stem+cells+progressing+to+the+clinic.">Pluripotent stem cells progressing to the clinic.</a> Nat. Rev. Mol. Cell Biol. 17 (3), 194-200 (2016).</li><li>Schmidt, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prenatally+fabricated+autologous+human+living+heart+valves+based+on+amniotic+fluid+derived+progenitor+cells+as+single+cell+source.">Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.</a> Circulation. 116 (11 Suppl), I64-I70 (2007).</li><li>Weber, B., Zeisberger, S. M., Hoerstrup, S. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prenatally+harvested+cells+for+cardiovascular+tissue+engineering:+Fabrication+of+autologous+implants+prior+to+birth.">Prenatally harvested cells for cardiovascular tissue engineering: Fabrication of autologous implants prior to birth.</a> Placenta. 32, S316-S319 (2011).</li><li>Weber, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prenatally+engineered+autologous+amniotic+fluid+stem+cell-based+heart+valves+in+the+fetal+circulation.">Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation.</a> Biomaterials. 33 (16), 4031-4043 (2012).</li><li>Kehl, D., Weber, B., Hoerstrup, S. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Bioengineered+living+cardiac+and+venous+valve+replacements:+current+status+and+future+prospects.">Bioengineered living cardiac and venous valve replacements: current status and future prospects.</a> Cardiovasc. Pathol. 25 (4), 300-305 (2016).</li><li>Slamecka, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Non-integrating+episomal+plasmid-based+reprogramming+of+human+amniotic+fluid+stem+cells+into+induced+pluripotent+stem+cells+in+chemically+defined+conditions.">Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.</a> Cell Cycle. 15 (2), 234-249 (2016).</li><li>Jiang, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+Transgene-Free+Amniotic-Fluid-Derived+Induced+Pluripotent+Stem+Cells+for+Autologous+Cell+Therapy.">Human Transgene-Free Amniotic-Fluid-Derived Induced Pluripotent Stem Cells for Autologous Cell Therapy.</a> Stem Cells Dev. 23 (21), 2613-2625 (2014).</li><li>Pipino, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Trisomy+21+mid-trimester+amniotic+fluid+induced+pluripotent+stem+cells+maintain+genetic+signatures+during+reprogramming:+implications+for+disease+modeling+and+cryobanking.">Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobanking.</a> Cell. Reprogram. 16 (5), 331-344 (2014).</li><li>Cai, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Generation+of+human+induced+pluripotent+stem+cells+from+umbilical+cord+matrix+and+amniotic+membrane+mesenchymal+cells.">Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells.</a> J Biol. Chem. 285 (15), 11227-11234 (2010).</li><li>Ge, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+Amniotic+Mesenchymal+Stem+Cell-Derived+Induced+Pluripotent+Stem+Cells+May+Generate+a+Universal+Source+of+Cardiac+Cells.">Human Amniotic Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells May Generate a Universal Source of Cardiac Cells.</a> Stem Cells Dev. 21 (15), 2798-2808 (2012).</li><li>Drozd, A. M., Walczak, M. P., Piaskowski, S., Stoczynska-Fidelus, E., Rieske, P., Grzela, D. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Generation+of+human+iPSCs+from+cells+of+fibroblastic+and+epithelial+origin+by+means+of+the+oriP/EBNA-1+episomal+reprogramming+system.">Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.</a> Stem Cell Res. Ther. 6 (1), (2015).</li><li>Kang, N. -. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Potential+antitumor+therapeutic+strategies+of+human+amniotic+membrane+and+amniotic+fluid-derived+stem+cells.">Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells.</a> Cancer Gene Ther. 19 (8), 517-522 (2012).</li><li>Moschidou, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Valproic+Acid+Confers+Functional+Pluripotency+to+Human+Amniotic+Fluid+Stem+Cells+in+a+Transgene-free+Approach.">Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach.</a> Mol. Ther. 20 (10), 1953-1967 (2012).</li><li>Kim, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Epigenetic+memory+in+induced+pluripotent+stem+cells.">Epigenetic memory in induced pluripotent stem cells.</a> Nature. 467 (7313), 285-290 (2010).</li><li>Chen, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Chemically+defined+conditions+for+human+iPSC+derivation+and+culture.">Chemically defined conditions for human iPSC derivation and culture.</a> Nature Methods. 8 (5), 424-429 (2011).</li><li>Yu, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+Induced+Pluripotent+Stem+Cells+Free+of+Vector+and+Transgene+Sequences.">Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences.</a> Science. 324 (5928), 797-801 (2009).</li><li>Mart&#237;, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+of+pluripotent+stem+cells.">Characterization of pluripotent stem cells.</a> Nat. Protoc. 8 (2), 223-253 (2013).</li><li>Chan, E. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Live+cell+imaging+distinguishes+bona+fide+human+iPS+cells+from+partially+reprogrammed+cells.">Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells.</a> Nat. Biotechnol. 27 (11), 1033-1037 (2009).</li><li>Adewumi, O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+of+human+embryonic+stem+cell+lines+by+the+International+Stem+Cell+Initiative.">Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.</a> Nat. Biotechnol. 25 (7), 803-816 (2007).</li><li>M&#252;ller, F. -. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+bioinformatic+assay+for+pluripotency+in+human+cells.">A bioinformatic assay for pluripotency in human cells.</a> Nature Methods. 8 (4), 315-317 (2011).</li><li>Cahan, P., Li, H., Morris, S. A., Lummertz da Rocha, E., Daley, G. Q., Collins, J. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CellNet:+Network+Biology+Applied+to+Stem+Cell+Engineering.">CellNet: Network Biology Applied to Stem Cell Engineering.</a> Cell. 158 (4), 903-915 (2014).</li><li>Schopperle, W. M., DeWolf, W. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+TRA-1-60+and+TRA-1-81+Human+Pluripotent+Stem+Cell+Markers+Are+Expressed+on+Podocalyxin+in+Embryonal+Carcinoma.">The TRA-1-60 and TRA-1-81 Human Pluripotent Stem Cell Markers Are Expressed on Podocalyxin in Embryonal Carcinoma.</a> STEM CELLS. 25 (3), 723-730 (2007).</li><li>Ohnishi, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Premature+Termination+of+Reprogramming+In+Vivo+Leads+to+Cancer+Development+through+Altered+Epigenetic+Regulation.">Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation.</a> Cell. 156 (4), 663-677 (2014).</li><li>Schlaeger, T. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+comparison+of+non-integrating+reprogramming+methods.">A comparison of non-integrating reprogramming methods.</a> Nature Biotechnology. 33 (1), 58-63 (2014).</li><li>M&#252;ller, F. -. J., Goldmann, J., L&#246;ser, P., Loring, J. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+call+to+standardize+teratoma+assays+used+to+define+human+pluripotent+cell+lines.">A call to standardize teratoma assays used to define human pluripotent cell lines.</a> Cell Stem Cell. 6 (5), 412-414 (2010).</li><li>Beers, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Passaging+and+colony+expansion+of+human+pluripotent+stem+cells+by+enzyme-free+dissociation+in+chemically+defined+culture+conditions.">Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions.</a> Nat. Protoc. 7 (11), 2029-2040 (2012).</li></ol>

Den indledende fase af iPSC generation fra føtale stamceller indebærer udvinding af kildecellerne fra de føtale væv, deres kultur, ekspansion og indførelsen af de episomal omprogrammering plasmider. Denne fase efterfølges af en kultur omkring 14-18 dage før de første fuldt omprogrammeret kolonier kan udvides. Den sidste fase er modning af iPSC kloner. Den indledende ekstraktion af fostervand membran stamceller er opnået ved hjælp af en kombineret mekaniske og Enzymatisk nedbrydning af dyr. Vi fandt, at en inkub...

Teknologien af induceret pluripotente stamceller (iPSC) bringer om potentielle celle udskiftning behandlingsformer, sygdom og udviklingsmæssige modellering, og narkotika og toksikologiske screening1,2,3. Udskiftning terapier kan konceptuelt opnås ved celle indsprøjtning, in vitro-opdelte væv (såsom hjerte patches) implantation eller guidede regenerering gennem vævsmanipulering. Fostervand (AFSC) og membran stamceller (AMSC) er en glimrende kilde til celler til disse interventioner enten direkte4,5,6,7 eller som en start celle population for omprogrammering i pluripotency8,9,10,11,12.
Tidlig tilgange bruges udefineret kultur systemer eller omprogrammering metoder, der kræver indebærer genomisk integration af konstruktioner9,10,11,12. En nyere undersøgelse ansat en xeno-frit medium, selv om en mindre definerede basalmembranen vedhæftet fil matrix (BMM) blev brugt til at generere iPSC fra fostervand væske epitelceller. Teratom dannelse analysen indgik ikke i undersøgelsen sammen med et væld af in vitro- og molekylære data. Fostervand væske epitelceller fandtes for at have en nogenlunde 8-fold højere omprogrammering effektivitet i forhold til neonatal fibroblaster13. I en anden undersøgelse fandtes mesenkymale stamceller fra fostervand også skal omprogrammeres til iPSC med en meget højere effektivitet12.
Pluripotente stamceller kan differentieres til væv repræsentant for alle 3 Kim lag og dermed har den bredeste potentiale. Pædiatriske patienter kunne drage fordel af den høst, omprogrammering, og vævsmanipulering af deres autolog fostervand væske stamceller prænatalt og fostervand membran stilk celler perinatal. Desuden kunne det forholdsvis lave niveau af differentiering af føtale stamceller (lavere end voksne stamceller14,15) teoretisk støtte i håndteringen af de observerede fastholdelse af epigenetiske bias fra kildecellerne i iPSC16.
Præsenterer her vi en protokol for omprogrammering fostervand og membran stamceller til pluripotency i kemisk definerede xeno-fri E8 medium rekombinante vitronectin17 (VTN) ved hjælp af episomal plasmider18. Den største fordel af fostervand væske og membran celler som en kilde til celler for omprogrammering ligger i deres tilgængelighed pre- og perinatal og dermed denne tilgang gavner hovedsagelig forskning i pediatric vævsmanipulering.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	
	<tbody>
		<tr >
			<td >Tumor Dissociation Kit, human</td>
			<td >Miltenyi Biotec</td>
			<td >130-095-929</td>
			<td >tissue dissociation system, reagent kit, includes tissue dissociation tubes and tissue dissociation enzymes</td>
		</tr>
		<tr >
			<td >gentleMACS Dissociator</td>
			<td >Miltenyi Biotec</td>
			<td >130-093-235</td>
			<td >tissue dissociation system, dissociator</td>
		</tr>
		<tr >
			<td >Thermo Scientific&#8482; Shandon&#8482; Disposable Scalpel No. 10, Sterile, Individually Wrapped, 5.75 (14.6cm)</td>
			<td >Thermo-Fisher</td>
			<td >3120032</td>
			<td ></td>
		</tr>
		<tr >
			<td >70 &#181;m cell strainers</td>
			<td >Corning</td>
			<td >10054-456</td>
			<td ></td>
		</tr>
		<tr >
			<td >RPMI 1640 medium</td>
			<td >Thermo-Fisher</td>
			<td >32404014&#160;</td>
			<td ></td>
		</tr>
		<tr >
			<td >rocking platform</td>
			<td >VWR</td>
			<td >40000-300</td>
			<td ></td>
		</tr>
		<tr >
			<td >50 ml centrifuge tubes</td>
			<td >Thermo-Fisher</td>
			<td >339652</td>
			<td ></td>
		</tr>
		<tr >
			<td >15 ml centrifuge tubes</td>
			<td >Thermo-Fisher</td>
			<td >339650</td>
			<td ></td>
		</tr>
		<tr >
			<td >EBM-2 basal medium</td>
			<td >Lonza</td>
			<td >CC-3156</td>
			<td >basal medium for AFMC medium</td>
		</tr>
		<tr >
			<td >FGF 2 Human (expressed in E. coli, non-glycosylated)</td>
			<td >Prospec Bio</td>
			<td >CYT-218</td>
			<td >bFGF, supplement for AFMC medium</td>
		</tr>
		<tr >
			<td >EGF Human, Pichia</td>
			<td >Prospec Bio</td>
			<td >CYT-332&#160;</td>
			<td >EGF, supplement for AFMC medium</td>
		</tr>
		<tr >
			<td >LR3 Insulin Like Growth Factor-1 Human Recombinant</td>
			<td >Prospec Bio</td>
			<td >CYT-022</td>
			<td >IGF, supplement for AFMC medium</td>
		</tr>
		<tr >
			<td >Fetal Bovine Serum, embryonic stem cell-qualified</td>
			<td >Thermo-Fisher</td>
			<td >10439024</td>
			<td >FBS</td>
		</tr>
		<tr >
			<td >Antibiotic-Antimycotic (100X)</td>
			<td >Thermo-Fisher</td>
			<td >15240062&#160;</td>
			<td >for primary AFSC/AMSC, for routine AFSC/AMSC it should not be necessary, do not use in medium for transfected cells!</td>
		</tr>
		<tr >
			<td >Accutase cell detachment solution</td>
			<td >StemCell Technologies</td>
			<td >07920</td>
			<td >cell detachment enzyme</td>
		</tr>
		<tr >
			<td >CryoStor&#8482; CS10</td>
			<td >StemCell Technologies</td>
			<td >07930</td>
			<td >complete freezing medium</td>
		</tr>
		<tr >
			<td >PBS, pH 7.4</td>
			<td >Thermo-Fisher Scientific</td>
			<td >10010023&#160;</td>
			<td ></td>
		</tr>
		<tr >
			<td >EndoFree Plasmid Maxi Kit (10)</td>
			<td >Qiagen</td>
			<td >12362</td>
			<td >for plasmid isolation</td>
		</tr>
		<tr >
			<td >pEP4 E02S EN2K</td>
			<td >Addgene</td>
			<td >20925</td>
			<td >EN2K, reprogramming factors Oct4+Sox2, Nanog+Klf4</td>
		</tr>
		<tr >
			<td >pEP4 E02S ET2K</td>
			<td >Addgene</td>
			<td >20927</td>
			<td >ET2K, reprogramming factors Oct4+Sox2, SV40LT+Klf4</td>
		</tr>
		<tr >
			<td >pCEP4-M2L</td>
			<td >Addgene</td>
			<td >20926</td>
			<td >M2L, reprogramming factors c-Myc+LIN28</td>
		</tr>
		<tr >
			<td >NanoDrop 2000c UV-Vis Spectrophotometer</td>
			<td >Thermo-Fisher</td>
			<td >ND-2000C</td>
			<td >spectrophotometer</td>
		</tr>
		<tr >
			<td >Neon&#174; Transfection System</td>
			<td >Thermo-Fisher</td>
			<td >MPK5000</td>
			<td >transfection system, components: 
			Neon pipette - transfection pipette 
			Neon device - transfection device</td>
		</tr>
		<tr >
			<td >Neon&#174; Transfection System 10 &#181;L Kit</td>
			<td >Thermo-Fisher</td>
			<td >MPK1025</td>
			<td >consumables kit for the Neon Transfection System, it contains: 
			Neon tip - transfection tip 
			Neon tube - transfection tube 
			buffer R - resuspension buffer 
			buffer E - electrolytic buffer</td>
		</tr>
		<tr >
			<td >Stemolecule&#8482; Sodium Butyrate</td>
			<td >StemGent</td>
			<td >04-0005</td>
			<td >small molecule enhancer of reprogramming</td>
		</tr>
		<tr >
			<td >TeSR-E8</td>
			<td >StemCell Technologies</td>
			<td >05940</td>
			<td >E8 medium</td>
		</tr>
		<tr >
			<td >Vitronectin XF&#8482;</td>
			<td >StemCell Technologies</td>
			<td >07180</td>
			<td >VTN, stock concentration 250 &#181;g/ml, used for coating at 1 &#181;g/cm2 in vitronectin dilution (CellAdhere) buffer</td>
		</tr>
		<tr >
			<td >CellAdhere&#8482; Dilution Buffer</td>
			<td >StemCell Technologies</td>
			<td >07183</td>
			<td >vitronectin dilution buffer</td>
		</tr>
		<tr >
			<td >UltraPure&#8482; 0.5M EDTA, pH 8.0</td>
			<td >Thermo-Fisher</td>
			<td >15575020</td>
			<td >dilute with PBS to 0.5 mM before use</td>
		</tr>
		<tr >
			<td >EVOS&#174; FL Imaging System</td>
			<td >Thermo-Fisher Scientific</td>
			<td >AMF4300</td>
			<td >LCD imaging microscope system</td>
		</tr>
		<tr >
			<td >CKX53 Inverted Microscope</td>
			<td >Olympus</td>
			<td ></td>
			<td >phase contrast cell culture microscope</td>
		</tr>
		<tr >
			<td >Pierce&#8482; 16% Formaldehyde (w/v), Methanol-free</td>
			<td >Thermo-Fisher</td>
			<td >28908</td>
			<td >dilute to 4% with PBS before use, diluted can be stored at 2-8 &#176;C for 1 week</td>
		</tr>
		<tr >
			<td >Perm Buffer III</td>
			<td >BD Biosciences</td>
			<td >558050</td>
			<td >permeabilization buffer, chill to -20 &#176;C before use</td>
		</tr>
		<tr >
			<td >Mouse IgG1, &#954; Isotype Control, Alexa Fluor&#174; 488</td>
			<td >BD Biosciences</td>
			<td >557782</td>
			<td >isotype control for Oct3/4A, Nanog</td>
		</tr>
		<tr >
			<td >Mouse IgG1, &#954; Isotype Control, Alexa Fluor&#174; 647</td>
			<td >BD Biosciences</td>
			<td >557783</td>
			<td >isotype control for Sox2</td>
		</tr>
		<tr >
			<td >Mouse anti-human Oct3/4 (Human Isoform A), Alexa Fluor&#174; 488</td>
			<td >BD Biosciences</td>
			<td >561628</td>
			<td ></td>
		</tr>
		<tr >
			<td >Mouse anti-human Nanog, Alexa Fluor&#174; 488</td>
			<td >BD Biosciences</td>
			<td >560791</td>
			<td ></td>
		</tr>
		<tr >
			<td >Mouse anti-human Sox-2, Alexa Fluor&#174; 647</td>
			<td >BD Biosciences</td>
			<td >562139</td>
			<td ></td>
		</tr>
		<tr >
			<td >Mouse IgGM, &#954; Isotype Control, Alexa Fluor&#174; 488</td>
			<td >BD Biosciences</td>
			<td >401617</td>
			<td >isotype control for TRA-1-60</td>
		</tr>
		<tr >
			<td >Mouse IgGM, &#954; Isotype Control, Alexa Fluor&#174; 647</td>
			<td >BD Biosciences</td>
			<td >401618</td>
			<td >isotype control for TRA-1-81</td>
		</tr>
		<tr >
			<td >Mouse anti-human TRA-1-60, Alexa Fluor&#174; 488</td>
			<td >BD Biosciences</td>
			<td >330613</td>
			<td ></td>
		</tr>
		<tr >
			<td >Mouse anti-human TRA-1-81, Alexa Fluor&#174; 647</td>
			<td >BD Biosciences</td>
			<td >330705</td>
			<td ></td>
		</tr>
		<tr >
			<td >Mouse IgG1, &#954; Isotype Control, Alexa Fluor&#174; 488</td>
			<td >BD Biosciences</td>
			<td >400129</td>
			<td >isotype control for SSEA-1</td>
		</tr>
		<tr >
			<td >Mouse IgG3, &#954; Isotype Control, Alexa Fluor&#174; 647</td>
			<td >BD Biosciences</td>
			<td >401321</td>
			<td >isotype control for SSEA-4</td>
		</tr>
		<tr >
			<td >Mouse anti-human SSEA-1, Alexa Fluor&#174; 488</td>
			<td >BD Biosciences</td>
			<td >323010</td>
			<td ></td>
		</tr>
		<tr >
			<td >Mouse anti-human SSEA-4, Alexa Fluor&#174; 647</td>
			<td >BD Biosciences</td>
			<td >330407</td>
			<td ></td>
		</tr>
		<tr >
			<td >Affinipure F(ab&#39;)2 Fragment Goat Anti-Mouse IgG+IgM, Alexa Fluor&#174; 488</td>
			<td >Jackson Immunoresearch</td>
			<td >115-606-068</td>
			<td >use at a dilution of 1:600 or further optimize</td>
		</tr>
		<tr >
			<td >Affinipure F(ab&#39;)2 Fragment Goat Anti-Mouse IgG+IgM, Alexa Fluor&#174; 647</td>
			<td >Jackson Immunoresearch</td>
			<td >115-546-068</td>
			<td >use at a dilution of 1:600 or further optimize</td>
		</tr>
		<tr >
			<td >DAPI</td>
			<td >Thermo-Fisher Scientific</td>
			<td >D21490</td>
			<td >stock solution 10 mM, further dilute to 1:12.000 for a working solution</td>
		</tr>
		<tr >
			<td >Corning&#174; Matrigel&#174; Growth Factor Reduced, Phenol Red-Free</td>
			<td >Corning</td>
			<td >356231</td>
			<td >basement membrane matrix (BMM)</td>
		</tr>
		<tr >
			<td >scid-beige mice, female</td>
			<td >Taconic</td>
			<td >CBSCBG-F</td>
			<td ></td>
		</tr>
		<tr >
			<td >RNeasy Plus Mini Kit (50)</td>
			<td >Qiagen</td>
			<td >74134</td>
			<td >RNA isolation kit</td>
		</tr>
		<tr >
			<td >T-25 flasks, tissue culture-treated</td>
			<td >Thermo-Fisher</td>
			<td >156367</td>
			<td ></td>
		</tr>
		<tr >
			<td >T-75 flasks, tissue culture-treated</td>
			<td >Thermo-Fisher</td>
			<td >156499</td>
			<td ></td>
		</tr>
		<tr >
			<td >Nunc&#8482; tissue-culture dish</td>
			<td >Thermo-Fisher</td>
			<td >12-567-650&#160;</td>
			<td >10 cm tissue culture dish</td>
		</tr>
		<tr >
			<td >6-well plates, tissue-culture treated</td>
			<td >Thermo-Fisher</td>
			<td >140675</td>
			<td ></td>
		</tr>
		<tr >
			<td >Neubauer counting chamber (hemacytometer)</td>
			<td >VWR</td>
			<td >15170-173</td>
			<td ></td>
		</tr>
		<tr >
			<td >Mr. Frosty&#8482; Freezing Container</td>
			<td >Thermo-Fisher</td>
			<td >5100-0001&#160;</td>
			<td >freezing container</td>
		</tr>
		<tr >
			<td >FACS tubes, Round Bottom Polystyrene Test Tube, 5ml</td>
			<td >Corning</td>
			<td >352058</td>
			<td >5 ml polystyrene tubes</td>
		</tr>
		<tr >
			<td >Eppendorf tubes, 1.5 ml</td>
			<td >Thermo-Fisher</td>
			<td >05-402-96</td>
			<td >1.5 ml microcentrifuge tubes</td>
		</tr>
		<tr >
			<td >PCR tubes, 200 &#181;l</td>
			<td >Thermo-Fisher</td>
			<td >14-222-262</td>
			<td ></td>
		</tr>
		<tr >
			<td >pipette tips, 100 to 1250 &#181;l</td>
			<td >Thermo-Fisher</td>
			<td >02-707-407</td>
			<td >narrow-bore 1 mL tips</td>
		</tr>
		<tr >
			<td >pipette tips, 5 to 300 &#181;l</td>
			<td >Thermo-Fisher</td>
			<td >02-707-410</td>
			<td ></td>
		</tr>
		<tr >
			<td >pipette tips, 0.1 to 10 &#181;l</td>
			<td >Thermo-Fisher</td>
			<td >02-707-437</td>
			<td ></td>
		</tr>
		<tr >
			<td >wide-bore pipette tips, 1000 &#181;l</td>
			<td >VWR</td>
			<td >89049-166</td>
			<td >wide-bore 1 mL tips</td>
		</tr>
		<tr >
			<td >glass Pasteur pipettes</td>
			<td >Thermo-Fisher</td>
			<td >13-678-20A</td>
			<td ></td>
		</tr>
		<tr >
			<td >ethanol, 200 proof</td>
			<td >Thermo-Fisher</td>
			<td >04-355-451</td>
			<td ></td>
		</tr>
		<tr >
			<td >vortex mixer</td>
			<td >VWR</td>
			<td >10153-842</td>
			<td ></td>
		</tr>
		<tr >
			<td >chambered coverglass, 8-well, 1.5mm borosilicate glass</td>
			<td >Thermo-Fisher</td>
			<td >155409</td>
			<td >glass-bottom confocal-grade cultureware</td>
		</tr>
		<tr >
			<td >22G needles</td>
			<td >VWR</td>
			<td >82002-366</td>
			<td ></td>
		</tr>
		<tr >
			<td >insulin syringes</td>
			<td >Thermo-Fisher</td>
			<td >22-253-260</td>
			<td ></td>
		</tr>
		<tr >
			<td >Formalin solution, neutral buffered, 10%</td>
			<td >Sigma-Aldrich</td>
			<td >HT501128-4L</td>
			<td >fixation of explanted teratomas</td>
		</tr>
		<tr >
			<td >Illumina HT-12 v4 Expression BeachChip</td>
			<td >Illumina</td>
			<td >BD-103-0204</td>
			<td >expression microarray, supported by PluriTest, discontinued by manufacturer</td>
		</tr>
		<tr >
			<td >PrimeView Human Genome U219 Array Plate</td>
			<td >Thermo-Fisher</td>
			<td >901605</td>
			<td >expression microarray (formerly Affymetrix brand), soon to be supported by PluriTest</td>
		</tr>
		<tr >
			<td >GeneChip&#8482; Human Genome U133 Plus 2.0 Array</td>
			<td >Thermo-Fisher</td>
			<td >902482</td>
			<td >expression microarray (formerly Affymetrix brand), supported by CellNet, soon to be supported by PluriTest</td>
		</tr>
		<tr >
			<td >PluriTest&#174;</td>
			<td >Coriell Institute</td>
			<td ></td>
			<td >www.pluritest.org, free service for bioinformatic assessment of pluripotency, accepts microarray data - *.idat files from HT-12 v4 platform, soon to support U133, U219 microarray and RNA sequencing data</td>
		</tr>
		<tr >
			<td >CellNet</td>
			<td >Johns Hopkins University</td>
			<td ></td>
			<td >cellnet.hms.harvard.edu, free service for bioinformatic identification of cell type, including plutipotent stem cells, based on U133 microarray data - *.cel files, soon to support RNA sequencing data</td>
		</tr>
	</tbody>
</table>

reprogramming primary amniotic fluid and membrane cells to pluripotency in xeno-free conditions

Autolog cellebaserede behandlinger fik et skridt tættere på virkeligheden med indførelsen af induceret pluripotente stamceller. Føtale stamceller, som fostervand og membran mesenkymale stamceller, repræsenterer en enestående type af udifferentierede celler med løftet i vævsmanipulering og for omprogrammering til iPSC for fremtidige pediatric interventioner og stamcelle bank. Protokollen præsenteres her beskriver en optimeret proceduren til ekstraktion og dyrkning af primære fostervand væske og membran mesenkymale stamceller og generere episomal induceret pluripotente stamceller fra disse celler som fuldt kemisk definerede kultur betingelser, der anvender humane rekombinante vitronectin og E8 medium. Karakterisering af de nye linjer ved at anvende strenge metoder – flowcytometri, Konfokal imaging, teratom dannelse og transcriptional profilering – er også beskrevet. De nyligt oprettede linjer express markører af embryonale stamceller-Oct3/4A, Nanog, Sox2, TRA-1-60, TRA-1-81, SSEA-4 – samtidig med at være negativ for SSEA-1 markør. Stamcellelinjer danner Teratomer i scid-beige mus i 6-8 uger og Teratomer indeholder væv repræsentativ for alle tre Kim lag. Transkriptionel profilering af linjerne ved at indsende globale udtryk microarray data til en bioinformatic pluripotency vurdering algoritmen anses for alle linjer pluripotente og derfor denne tilgang er et attraktivt alternativ til dyreforsøg. De nye iPSC linjer kan let anvendes downstream forsøg med optimering af differentiering og vævsmanipulering.

Informeret skriftligt samtykke blev opnået fra patienter før høsten fostervand for genetiske testformål og afsætte en lille prøve af væsken for forskning. Ingen samtykke er påkrævet for brug af fostervand membranen i forskning som moderkagen repræsenterer medicinsk affald. Fostervand væske og membran stamceller viser typiske mesenchymale egenskaber, morfologisk deres celler er spindel-formet og fase-lyse. Ved omprogrammering, cellerne gennemgå mesenchymale til epitel (MET) ove...

Watch this Scientific Journal Video about Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions at JoVE.com

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Denne protokol beskriver omprogrammering af primære fostervand væske og membran mesenkymale stamceller til induceret pluripotente stamceller ved hjælp af en ikke-integrere episomal tilgang i fuldt kemisk definerede betingelser. Procedurer for udvinding, kultur, omprogrammering og karakterisering af de resulterende inducerede pluripotente stamceller af strenge metoder er beskrevet.

Omprogrammering primære fostervand og membran celler til Pluripotency i Xeno-fri betingelser

Autologous cell-based therapies got a step closer to reality with the introduction of induced pluripotent stem cells. Fetal stem cells, such as amniotic ...

Research

JoVE Journal

Developmental Biology

Stable and Efficient Genetic Modification of Cells in the Adult Mouse V-SVZ for the Analysis of Neural Stem Cell Autonomous and Non-autonomous Effects

Stabil og effektiv genetisk modificering af celler i Voksen Mouse V-SVZ til analyse af neural stamcelle selvstyrende og ikke-selvstændige effekter

Relatively quiescent somatic stem cells support life-long cell renewal in most adult tissues. Neural stem cells in the adult mammalian brain are ...

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System

Produktionen af ​​pluripotente stamceller fra mus fostervand Celler Ved hjælp af en Transposon System

Induced pluripotent stem (iPS) cells are generated from mouse and human somatic cells by forced expression of defined transcription factors using ...

Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell (MSC) Spheroids Primed in 3-D Cultures Under Xeno-free Conditions

Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell MSC Spheroids Primed in 3-D Cultures Under Xeno-free Conditions

Produktion og administration af terapeutiske mesenchymstamceller / Stromal Cell (MSC) Spheroids Primed i 3-D kulturer Under Xeno-frie betingelser

Mesenchymal stem/stromal cells (MSCs) hold great promise in bioengineering and regenerative medicine. MSCs can be isolated from multiple adult tissues via ...

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Betinget Omprogrammering af Pediatric Menneskelig Esophageal epitelceller til brug i Tissue Engineering og Sygdom Investigation

Identifying and expanding patient-specific cells in culture for use in tissue engineering and disease investigation can be very challenging. Utilizing ...

Computational Analysis of the Caenorhabditis elegans Germline to Study the Distribution of Nuclei, Proteins, and the Cytoskeleton

Computational Analysis of the Caenorhabditis elegans Germline to Study the Distribution of Nuclei, Proteins, and the Cytoskeleton

Beregningsmæssige analyse af Caenorhabditis elegans kønscelleoverførsel at studere Distribution kerner, proteiner og cytoskelettet

The Caenorhabditis elegans (C. elegans) germline is used to study several biologically important processes including stem cell development, apoptosis, and ...

Induction and Validation of Cellular Senescence in Primary Human Cells

Induktion og validering af cellulære gulne i primære humane celler

Cellular senescence is a state of permanent cell cycle arrest activated in response to different damaging stimuli. Activation of cellular senescence is a ...

Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models

Definerede Xeno-fri og Feeder-fri kultur betingelser for den Generation af menneskelige iPSC-afledte Retinal Cell modeller

The production of specialized cells from pluripotent stem cells provides a powerful tool to develop new approaches for regenerative medicine. The use of ...

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model

Intravenøs og Intra-fostervand In Utero Transplantation i Murine Model

In utero transplantation (IUT) is a unique and versatile mode of therapy that can be used to introduce stem cells, viral vectors, or any other substances ...

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Induktion i Endothelial differentiering i hjertets stamceller lavt Serum betingelser

Cardiac progenitor cells (CPCs) may have therapeutic potential for cardiac regeneration after injury. In the adult mammalian heart, intrinsic CPCs are ...

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Direkte afstamning omprogrammering af voksne mus Fibroblast til Erythroid ophav

Erythroid cell commitment and differentiation proceed through activation of a lineage-restricted transcriptional network orchestrated by a group of cell ...